{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T15:29:57Z","timestamp":1773502197102,"version":"3.50.1"},"reference-count":16,"publisher":"Japanese Society of Internal Medicine","issue":"15","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2025,8,1]]},"DOI":"10.2169\/internalmedicine.4737-24","type":"journal-article","created":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T17:12:10Z","timestamp":1736874730000},"page":"2382-2385","source":"Crossref","is-referenced-by-count":1,"title":["Life-threating Asthma Exacerbation Successfully Treated with Benralizumab"],"prefix":"10.2169","volume":"64","author":[{"given":"Suzuka","family":"Matsuoka","sequence":"first","affiliation":[{"name":"Department of Respiratory Medicine, NHO Okayama Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichiro","family":"Kudo","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, NHO Okayama Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayu","family":"Goda","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, NHO Okayama Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoyoshi","family":"Inoue","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, NHO Okayama Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toki","family":"Kitano","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, NHO Okayama Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuto","family":"Sasano","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, NHO Okayama Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiichi","family":"Fujiwara","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, NHO Okayama Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Bourdin A, Charriot J, Boissin C, et al. Will the asthma revolution fostered by biologics also benefit adult ICU patients? Allergy 76: 2395-2406, 2021.","DOI":"10.1111\/all.14688"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Binachon A, Grateau A, Allou N, et al. Acute severe asthma requiring invasive mechanical ventilation in the era of modern resuscitation techniques: a 10-year bicentric retrospective study. PLOS ONE 15: e0240063, 2020.","DOI":"10.1371\/journal.pone.0240063"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Milger K, Schroeder I, Behr J, Meis T, Wulffen WV, Kneidinger N. Omalizumab rescue therapy for refractory status asthmaticus. Ann Intern Med 170: 351-352, 2019.","DOI":"10.7326\/L18-0359"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Benes J, Skulec R, Jilek D, Fibigr O, Cerny V. Successful treatment of refractory status asthmaticus with omalizumab: a case report. Allergy Asthma Clin Immunol 17: 128, 2021.","DOI":"10.1186\/s13223-021-00629-z"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Slevogt H, Brauer M. Rescue therapy for refractory status asthmaticus with updosed omalizumab adjusted for IgE level, body weight and effect. Respir Med Case Rep 36: 101614, 2022.","DOI":"10.1016\/j.rmcr.2022.101614"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Tello K, Hoffmann A, Beutel B, et al. Anti-interleukin-5 therapy (mepolizumab) in life-threatening asthma attack: a case-based discussion. Respir Med Case Rep 28: 100927, 2019.","DOI":"10.1016\/j.rmcr.2019.100927"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Barbarot N, Nourry E, Massart N, et al. Treating acute severe eosinophilic asthma with IL-5 inhibitors in ICU. Case Rep Pulmonol 2022: 2180795, 2022.","DOI":"10.1155\/2022\/2180795"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Rodrigues HC, Martins C, Fragoso E, Lopes C, Azevedo P. Mepolizumab in severe asthma exacerbation in a respiratory ICU- a successful off-label use. Pulmonology 29: 438-440, 2023.","DOI":"10.1016\/j.pulmoe.2023.03.002"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Grasmuk-Siegl E, Xhelili E, Doberer D, Urban MH, Valipour A. Tezepelumab in a case of severe asthma exacerbation and influenza-pneumonia on VV-ECMO. Respir Med Case Rep 50: 102057, 2024.","DOI":"10.1016\/j.rmcr.2024.102057"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. P\u00e9rez de Llano LP, Blanco Cid N, Ortiz Piquer M, Dacal Rivas D. Compassionate use of a single dose of Benralizumab in a near-fatal asthma exacerbation. J Investig Allergol Clin Immunol 31: 268-270, 2021.","DOI":"10.18176\/jiaci.0609"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Montagnolo F, Grasso S, Dalfino L, et al. Successful benralizumab treatment in acute near-fatal asthma with ECMO support: a case report. J Asthma 61: 1790-1793, 2024.","DOI":"10.1080\/02770903.2024.2375287"},{"key":"12","doi-asserted-by":"publisher","unstructured":"12. Yamauchi Y, Yasunaga H, Matsui H, et al. Comparison of in-hospital mortality in patients with COPD, asthma and asthma-COPD overlap exacerbations. Respirology 20: 940-946, 2015.","DOI":"10.1111\/resp.12556"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Kaur BP, Lahewala S, Arora S, et al. Asthma: hospitalization trends and predictors of in-hospital mortality and hospitalization costs in the USA (2001-2010). Int Arch Allergy Immunol 168: 71-78, 2015.","DOI":"10.1159\/000441687"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Dunican EM, Elicker BM, Gierada DS, et al. Mucus plugs in patients with asthma linked to eosinophilia and airflow obstruction. J Clin Invest 128: 997-1009, 2018.","DOI":"10.1172\/JCI95693"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Sakai N, Koya T, Murai Y, et al. Effect of benralizumab on mucus plugs in severe eosinophilic asthma. Int Arch Allergy Immunol 184: 783-791, 2023.","DOI":"10.1159\/000530392"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Laviolette M, Gossage DL, Gauvreau G, et al. Effects of benralizumab on airway eosinophils in asthmatic patients with sputum eosinophilia. J Allergy Clin Immunol 132: 1086-1096.e5, 2013.","DOI":"10.1016\/j.jaci.2013.05.020"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/15\/64_4737-24\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T04:15:54Z","timestamp":1754108154000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/15\/64_4737-24\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,1]]},"references-count":16,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.4737-24","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,1]]},"article-number":"4737-24"}}